The new Jules Bordet Institute presents its best wishes for 2022!
Together may we continue to rise to new challenges and make further progress in the fight against cancer.
(read more)
Actualité du 15/12/2021
Une équipe d’expérience pour diriger l’Hôpital Universitaire de Bruxelles (H.U.B)
Le Conseil d’administration de l’H.U.B a désigné Renaud Witmeur et le Professeur Jean-Michel Hougardy respectivement comme Directeur Général et Directeur Général Médical de l’Hôpital Universitaire de Bruxelles (H.U.B).
L’H.U.B regroupe l’Hôpital Erasme, l’Institut Jules Bordet et l’Hôpital Universitaire des Enfants Reine Fabiola (…
(read more)
News : 08/12/2021
The Christmas Market is coming to the New Jules Bordet Institute!
Sunday 12 and Monday 13 December from 12 noon to 6 pm the central aisle of the New Institute will be ready to welcome the Christmas Market complete with Christmas lights and decorations!
Delicacies, handicrafts and many other great ideas for gifts will be on display.
All profits will go to the Jules Bordet Association and the Wellbeing Fund for…
(read more)
08/11/2021
The Jules Bordet Institute lends its full support to the international Movember campaign that every year alerts public opinion to male cancers and raises funds for research into such male diseases as prostate cancer.
There is no mistaking the figures: Prostrate cancer is the second most common cancer after breast cancer with more than 10,000 new cases recorded every year in Belgium. It cannot be stressed enough that …
(read more)
08/11/2021
When facing cancer, think of the trio: healthy diet, physical exercise and healthy weight
The Jules Bordet Institute, reference centre in the fight against cancer, is supporting Nutrition Day with a reminder of three essential factors to be considered when facing cancer: a healthy diet, regular physical exercise and maintaining a healthy weight.
When facing cancer, be sure to follow a healthy diet
The…
(read more)
11/10/2021
Sunday 17 October is the day you can come and discover the brand new Jules Bordet Institute, the reference centre in the fight against cancer in Belgium.
Covid Safe Event: Advance booking and Covid Safe ticket required
I want to book
What:
The Jules Bordet Institute, the internationally renowned multidisciplinary university hospital for the fight against cancer, invites you to discover its new…
(read more)
14/09/2021
Basile Stamatopoulos, researcher at the Jules Bordet Institute, receives the Bekales Prize
This 11 September, the Belgian Royal Academy of Medicine awarded the Bekales Prize to Prof. Basile Stamatopoulos, Doctor of biomedical and pharmaceutical sciences from the Université Libre de Bruxelles, lecturer at the Faculty of Medicine and researcher at the Clinical Cellular Therapy Research Laboratory of the Jules Bordet…
(read more)
Press Release (30/08/2021)
The MyPeBS clinical study: for a new breast cancer screening strategy?
30 August 2021 - The aim of MyPeBS (My Personal Breast Cancer Screening) is to evaluate a breast cancer screening strategy based on individual risk. A total of 27 international partners are participating in MyPeBS. The clinical study is taking place in six countries (Belgium, France, Italy, the…
(read more)
17/08/2021
The Jules Bordet Institute, the reference centre in the fight against cancer in Belgium, is publishing a magazine on its plans to move to a brand new building. Discover more about this ambitious project!
After more than 80 years active in the heart of Brussels (Porte de Hal), the Jules Bordet Institute is moving to a new building to pursue its major role in the fight against cancer and to respond to major developments in…
(read more)
10/08/2021
Delivery of the first MRI-Linac 1.5 Tesla in Belgium to the Radiotherapy Department of the New Jules Bordet Institute!
This very latest radiotherapy equipment combines the benefits of a linear particle accelerator and the precision of an MRI system. It will enable the Institute to adapt treatment on a daily basis as a tumour evolves and thereby protect healthy tissue to a maximum. One more step towards perfecting our cancer…
(read more)